[Functional determination of C1-inhibitors in human blood].
The author describes the method of assessment of the C1-inhibitor, the principle being activation of plasma prekallikrein by Hageman factor fragment (HFf) to the active enzyme kallikrein which splits the specific chromogenic substrate NO-Pro-Phe-Arg-pNA. In the presence of acetone the influence of C1-INH is eliminated and the assessed amount of kallikrein corresponds to the prekallikrein plasma level. In a parallel estimation without acetone after formation of the C1-INH complex the residual amount of kallikrein is assessed. The difference between the two levels is proportional to the formed enzyme-inhibitor complex. The method was tested on plasma of healthy donors and the results were compared with assessment of C1-INH by a modification of Schapira's method (6) (correlation coefficient r = 0.88) and with Cullmann's method (8) (r = 0.61). The advantage of the proposed method is that it does not require commercially unavailable enzyme preparations, that it uses as activating agent HFf concentrate, prepared in the laboratory and that along with the C1-INH level also the plasma level of prekallikrein is assessed.
Simonianová
E
E
Ustav hematologie a krevní transfúze, Praha.
D003174:Complement C1 Inactivator Proteins / Q000032:analysis*; D006403:Hematologic Tests / Q000379:methods; D006801:Humans; D011288:Prekallikrein / Q000032:analysis
D003174:Complement C1 Inactivator Proteins; D011288:Prekallikrein
Funkcní stanovení C1-inhibitoru v lidské krevní plazmĕ.